A method of determining the presence and quantity of an analyte of interest in a particulate-containing sample is disclosed, as is a construct for use in the method. The method is particularly useful for determining an analyte in whole blood and in fermentation suspensions. The construct is comprised of a first moiety, which is a particulate-binding moiety and a second moiety, which binds the analyte of interest.
5086002 - Erythrocyte agglutination assay - Owned by Agen Biomedical, Ltd. (Acacia Ridge,AU) [*] Notice:The portion of the term of this patent subsequent to January 16, 2007 has been disclaimed.
In a novel, erythrocyte agglutination assay, the agglutination reagent comprises at least one erythrocyte binding molecule coupled to at least one specific analyte binding molecule wherein the erythrocyte binding molecule does not cause agglutination when incubated with erythrocytes in the absence of analyte (in the case of a direct assay) or analyte binding reagent (in the case of an indirect assay). Preferably, the erythrocytes are endogenous to the blood sample to be tested, that is, a whole blood sample is assayed. Mixtures of conjugates and conjugates of analyte analogues with erythrocyte binding molecules may also be used as agglutination reagents. The reagents and their use in direct or indirect assays is disclosed.
An indicator reagent, assay method and test kit for determining the presence or amount of an analyte in a test sample, in which the indicator reagent is formed by attaching an organic polymer latex particle, preferably a colored particle, to a specific binding member. The specific binding member can be adsorbed onto or covalently bound to the organic polymer latex particles. The organic polymer latex particles are readily detected by direct visual observation or can be detected and/or measured by appropriate instrumentation.
A method of determining the presence and quantity of an analyte of interest in a particulate-containing sample is disclosed, as is a construct for use in the method. The method is particularly useful for determining an analyte in whole blood and in fermentation suspensions. The construct is comprised of a first moiety, which is a particulate-binding moiety and a second moiety, which binds the analyte of interest.
Assessment of the number of somatic cells in a liquid milk or milk product analyte material comprises arranging a volume of a liquid sample representing the analyte material in a sample compartment and allowing electromagnetic signals from the sample in the compartment to pass through and be exposed to the exterior. There is exposed onto an array of active detection elements, an at least one-dimensional spatial representation of electromagnetic signals from the sample. The representation is detectable as an intensity by individual active detection elements. Representations of electromagnetic signs from the somatic cells are identified. The size of the volume of the liquid sample is sufficiently large to permit the assessment of the number of somatic cells to fulfill a predetermined requirement to the statistically quality of the assessment based on substantially one exposure.
